New recommendations for prescribing Bayer’s AndrocurLa Croix reported in a brief on Tuesday (p.10) that France’s drug regulator ANSM has set up new recommendations for prescribing Bayer’s Androcur in indications such as acne and moderate hirsutism, to include a brain MRI scan.
Growing Depakine scandal worries insurersLes Echos reported on Thursday (p.30) that French healthcare professional insurers are starting to worry about the impact of the scandal surrounding Sanofi’s Depakine (APMHE 42992).
Shared medical filesLe Figaro reports in a brief on Friday (p.23) that France’s health insurance and the French national union of healthcare professionals aim to create 40 million shared medical files (DMP) in the next five years.
New head of HAS general secretariatLes Echos reported on Monday (p.34) that Cecile Lambert will be the new head of the general secretariat of French health technology assessment board HAS as of 1 December.
Sanofi inaugurates new plant in AlgeriaLes Echos reports on Friday (p.32) that Sanofi inaugurated a new production plant in Algeria at a cost of €85 million. Philippe Luscan, head of industrial affairs at the company, said the plan “will allow Sanofi’s production capabilities in the country to be doubled to 100 million boxes a year”.
Several candidates bidding to buy OTC branch of BMS FranceGerman generic manufacturer Stada, French pharma Pierre Fabre and capital investment funds are competing to buy Upsa, the over-the-counter (OTC) medicines branch of BMS, Les Echos said in a brief on Tuesday (p.19).
Inhaler and diabetes pen manufacturer Nemera up for saleInhaler and diabetes pen manufacturer Nemera is on sale for more than €1 billion, Les Echos reported on Thursday (p.26).
Auvergne launches sixth 'New Deal' package to attract biotechsThe French region of Auvergne is launching a “New Deal” package for the sixth year in a row in a bid to attract biotech companies to the region, Le Figaro reported on Wednesday (p.21).
Meditech wins ‘Best Tech Start-up of the Year’Meditech won ‘Best Tech Start-up of the Year’ at the investment forum Start & MeetUP organised by the EmTech Europe 2018 congress, Les Echos reported in a brief on Wednesday (p.27).
Embleema plans to make health data secureLes Echos ran a short article on Thursday (p.24) on Embleema, a start-up that plans to make health data secure using blockchain. Embleema aims to get patients involved, and reimbursed, for giving their “real world data” to pharma companies.
Publicis wins contract to become GSK's global media agencyLes Echos reported on Tuesday (p.22) that French group Publicis has won the contract to become GlaxoSmithKline's global media agency.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.